Double Blind Controlled Trial In Benign Prostatic Hyperplasia Using Individualized Homoeopathic Medicine And Homoeopathic Dilution Of Conium Maculatum - A Two Arm Randomized Controlled Trial

This study is a Double Blind Controlled Trial in Benign Prostatic Hyperplasia using Individualized Homoeopathic Medicine and Homoeopathic Dilution of Conium maculatum - a two arm Randomized Controlled Trial, that will be conducted in the Outpatient and Inpatient departments, Peripheral centers and Camps conducted under the Department of Practice of Medicine, National Homoeopathy Research Institute in Mental Health, Kottayam. The primary outcome measure will be, the changes in Prostatic Volume (PV) in Ultrasound scan which will be measured every 5 months (at Baseline, 5th month and at the end of the study). The secondary outcomes will be, changes in Post Void Residual Urine (PVRU) Volume in Ultrasound scan measured at Baseline, 5th month and at the end of the study and Changes in International Prostate Symptom Score (IPSS) measured every month from baseline to the end of the study. Since there hasn’t been any studies conducted solely to explore the effectiveness of Conium maculatum in Benign Prostatic Hyperplasia cases, conducting a double blind randomized controlled trial, may help in unveiling and exploring more therapeutic actions of Conium in this regard.